Hongsik Kim

8PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 26, 2026
Associations of Multiple Serum Tumor Markers with Radiological Response and Overall Survival in Patients with Advanced Gastric Cancer Receiving First-Line Palliative Systemic Therapy.

|Oct 15, 2025
Distinct Immunosuppressive Tumor Microenvironment in Gastric Cancer With Peritoneal Metastasis.

Hongsik Kim, Minsuk Kwon, Sun Kyung Lee

|Oct 02, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin.

Hongsik Kim, Chiyoon Oum, Soo Ick Cho

|Apr 26, 2025
Targeted Suppression of CEACAM6 via pHLIP-Delivered RNAs in Pancreatic Ductal Adenocarcinoma.

Hongsik Kim, Chang-Gok Woo, Seung-Myoung Son

|Aug 02, 2024
Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study.

Minkwan Cho, Eunkyung Park, Yong-Pyo Lee

|Aug 22, 2022
Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer.

Hongsik Kim, Ryul Kim, Hyunji Jo

Pageof 2

Frequent Collaborators

2 joint publications

Hye Sook Han

2 joint publications

Yaewon Yang

1 joint publications

Miso Kim

1 joint publications

Youngjoo Lee